TrialBritish journal of cancer2003

Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer.

F Lordick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.